Reading Christopher

Avg. Two Year Performance

No purchase track record
89% Avg. Sale Return
38% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return50%52%72%66%89%
Sale Success Rate1 of 11 of 11 of 11 of 11 of 1
Drugs » Biotechnology

Chief Scientific Officer:

Holdings: 8.63K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--
Other » Other

EVP Neuroscience R&D:

Holdings: 37.15K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--